Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Anglo seeks damages as Peabody pulls out of $3.8bn coal sale

(Sharecast News) - American coal miner Peabody has officially pulled out of the $3.8bn move to take over Anglo American's steelmaking coal business in Australia, blaming a contested 'material adverse change' to the deal first announced last November. The breakdown of the agreement follows a fire at the Moranbah North mine at the end of March, which Peabody claimed had materially changed the initial terms of the deal.

Peabody then announced in April that it was reviewing the deal, citing the MAC clause.

"The two companies did not reach a revised agreement to cure the MAC that compensated Peabody for the material and long-term impacts of the MAC on the most significant mine in the planned acquisition," Peabody's president and chief executive Jim Grech said in a statement.

Peabody shares jumped as much as 3% in early deals on Wall Street, but trimming gains to 0.8% by 0942 ET.

Anglo, which said it continues to make progress towards a "safe restart" of Moranbah North, reiterated on Tuesday that the fire did not constitute a MAC under the original agreement, given the absence of damage to the mine and equipment.

As a result, the company said it will soon start an "arbitration to seek damages for wrongful termination".

"Our view is supported by the lack of damage to the mine and equipment, as well as the substantial progress made with the regulator, our employees and the unions, and other stakeholders as part of the regulatory process towards a safe restart of the mine," said Anglo's CEO Duncan Wanblad.

"In fact, just in the last week we achieved a further important milestone, with our workforce signing off the risk assessment that underpins the restart strategy. We are therefore very disappointed that Peabody has decided not to complete the transaction."

Looking ahead, Wanblad said the company was confident that it would successfully conclude an alternative sales process for the assets "in due course" following the inbound interest received in recent months.

Anglo's share price was up 1.7% at 2,167p by 1447 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.